Related Experiment Video
Updated: Oct 12, 2025

Establishment and Characterization of UTI and CAUTI in a Mouse Model
Published on: June 23, 2015
Antibiotic Resistance in Paediatric Febrile Urinary Tract Infections
Susanna Esposito1, Giacomo Biasucci2, Andrea Pasini3
1Paediatric Clinic, University Hospital, Department of Medicine and Surgery, University of Parma, Parma, Italy.
Insights
Febrile urinary tract infections (UTIs) in children are common serious bacterial illnesses. Rising antibiotic resistance necessitates careful antibiotic selection and stewardship to ensure effective treatment and prevent complications.
Area of Science:
- Pediatric infectious diseases
- Antimicrobial resistance
- Clinical microbiology
Background:
- Febrile urinary tract infection (UTI) is a frequent cause of serious bacterial illness in young children.
- Untreated or inadequately treated UTIs can lead to irreversible renal damage and chronic renal insufficiency.
- Increasing antibiotic resistance among UTI pathogens complicates treatment decisions and necessitates updated therapeutic strategies.
Purpose of the Study:
- To review the emerging problem of antibiotic resistance in pediatric febrile UTIs.
- To discuss potential solutions for ensuring effective antibiotic therapy in this population.
- To highlight the importance of antibiotic stewardship in combating resistance.
Main Methods:
- Literature analysis of emerging antibiotic resistance patterns in pediatric UTI pathogens.
- Review of current recommendations and challenges in empiric antibiotic therapy.
- Discussion of strategies to reduce and rationalize antibiotic consumption.
Main Results:
- Antibiotic resistance among UTI pathogens is a growing concern, rendering treatment guidelines rapidly outdated.
- Pathogen susceptibility to antibiotics varies, impacting the choice of effective therapy.
- The emergence of antibiotic resistance is closely linked to antibiotic usage.
Conclusions:
- Early and effective antibiotic treatment is crucial to prevent renal damage and other complications in pediatric UTIs.
- Reducing and rationalizing antibiotic consumption through antibiotic stewardship is essential to limit the emergence of resistance.
- Identifying children at high risk for difficult-to-treat UTIs can improve therapeutic outcomes.
Abstract:
Febrile urinary tract infection (UTI) is currently considered the most frequent cause of serious bacterial illness in children in the first 2 years of life. UTI in paediatrics can irreversibly damage the renal parenchyma and lead to chronic renal insufficiency and related problems. To avoid this risk, an early effective antibiotic treatment is essential. Moreover, prompt treatment is mandatory to improve the clinical condition of the patient, prevent bacteraemia, and avoid the risk of bacterial localization in other body sites. However, antibiotic resistance for UTI-related bacterial pathogens continuously increases, making recommendations rapidly outdated and the definition of the best empiric antibiotic therapy more difficult. Variation in pathogen susceptibility to antibiotics is essential for the choice of an effective therapy. Moreover, proper identification of cases at increased risk of difficult-to-treat UTIs can reduce the risk of ineffective therapy. In this review, the problem of emerging antibiotic resistance among pathogens associated with the development of paediatric febrile UTIs and the best potential solutions to ensure the most effective therapy are discussed. Literature analysis showed that the emergence of antibiotic resistance is an unavoidable phenomenon closely correlated with the use of antibiotics themselves. To limit the emergence of resistance, every effort to reduce and rationalise antibiotic consumption must be made. An increased use of antibiotic stewardship can be greatly effective in this regard.
More Related Videos
Related Concept Videos
Urine Studies II: Urine Culture and Sensitivity Test
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Infection II: Pathophysiology
Development of Antibiotic Resistance
Acute Pyelonephritis II: Diagnostic Studies and Management
Pharmacokinetics in Pediatric Patients: Drug Excretion

